Canopy Growth (CGC) Stock Plummets 99%, Uncertain Future Ahead
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 14 2026
0mins
Source: Fool
- Stock Price Collapse: Canopy Growth's stock has plummeted over 99% in the past five years, with a current market cap of $500 million, indicating a failure in its rapid expansion strategy and severely undermining investor confidence.
- Operating Loss Improvement: For the quarter ending September 30, Canopy Growth reported an operating loss of CAD 16.9 million, an improvement from CAD 45.9 million a year ago, yet it still highlights the financial pressures the company faces.
- Slowed Cash Burn: Over the past six months, the company used CAD 28.3 million in daily operations, significantly down from CAD 105.6 million in the same period last year, indicating some progress in cost control efforts.
- Declining Revenue: The latest quarter's revenue was just under CAD 83 million, a 30% decline from nearly CAD 118 million three years ago, reflecting the company's competitive disadvantages and challenges for future growth.
Analyst Views on CGC
Wall Street analysts forecast CGC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CGC is 3.78 USD with a low forecast of 1.80 USD and a high forecast of 5.76 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
1 Buy
2 Hold
0 Sell
Moderate Buy
Current: 1.190
Low
1.80
Averages
3.78
High
5.76
Current: 1.190
Low
1.80
Averages
3.78
High
5.76
About CGC
Canopy Growth Corporation is a Canada-based cannabis company. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company delivers innovative products from owned and licensed brands, including Tweed, 7ACRES, DOJA, Deep Space, and Claybourne, as well as category defining vaporization devices by Storz & Bickel. Its segments include Canada cannabis, and Storz & Bickel. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers. In addition, it serves medical cannabis patients globally with principal operations in Canada, Europe and Australia.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
